Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer “Revision” number was updated from v3.5.2 to v3.5.3, indicating a site/backend version change rather than a change to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:21:13.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:36:07.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    Added the disease category Squamous cell carcinoma of the head and neck and introduced a Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:11:21.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed. The update does not modify study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-19T04:59:00.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible content changes on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:26:02.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Page updated to Revision: v3.4.2 and the government funding status notice was removed; no study content or eligibility criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:12:44.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.